Cisuba
       
home email Sitemap Sitemap  
Home Contact Us Sitemap Login  
 
Mission
 
 
new products
News
Launching of Diovan 320 mg..


Mr. Mohit Malhotra Visit to Sudan..


Launching of Elidel Cream..


News
Launching of Elidel Cream
Advantages
• ELIDEL (pimecrolimus) Cream 1% is the first steroid-free prescription cream that controls the itching and redness of eczema. It is for people ages 2 and older who have mild to moderate eczema. (This accounts for most of the people with eczema.)
• Many patients suffer from eczema on sensitive skin and/or suffer from flares frequently. These patients need an alternative to topical steroids, to treat sensitive skin when steroids cannot be used or to provide a break from frequent use of steroids.
• Does not cause certain side effects, such as thinning of the skin, stretch marks, skin discoloration, or spider veins.
• ELIDEL meets the challenges of eczema management without skin atrophy, striae, telangiectasia, hypopigmentation, tachyphylaxis, rebound flares, vasoconstriction, or HPA axis suppression
• ELIDEL Cream is approved by the FDA for people ages 2 and older.
• ELIDEL is for use on the skin only, and only to treat eczema. ELIDEL can be used on any skin surface, even on the most delicate skin areas such as the face and neck and around the eyes.
• Apply a thin layer of ELIDEL twice a day to control the itching and redness of eczema.
• Unlike most ointments, not only is ELIDEL Cream non-greasy, it has no odor. Because it's non-greasy and absorbs quickly, it shouldn't stain clothes or sheets.
• ELIDEL is indicated for short-term and intermittent long-term treatment of atopic dermatitis.
• Fight mild or moderate Eczema right where it starts.
• Low incidence of local side effects
• Published data indicate that eight out of nine people with eczema see symptoms before the age of five years.
• Elidel is an effective non-steroid topical treatment for mild-to-moderate eczema, with a favorable safety profile.
• Elidel has been shown to:

 Reduce the number of flares-ups by around 50% when used with steroids vs. treatment with steroids alone
 Prolong the time between flare-ups (144 days vs. 26 days with conventional treatment)
 Reduce the severity of flare ups by an average of 50%
 Reduce the need for treatment over time as the disease became better controlled
 
 
 
Home  |  About Us  |  About Sudan  |  Products  |  News & Events  |  Useful Links  |  Contact Us
Copyright © 2007, Cisuba. All rights reserved.